Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Silence sets up SAB to strengthen liver pipeline

This article was originally published in Scrip

Executive Summary

RNA interference company Silence Therapeutics has created a scientific advisory board with the appointment of two key opinion leaders in the area of liver diseases, Professors Detlef Schuppan and Massimo Pinzani. Professor Schuppan is a consultant gastroenterologist and hepatologist, director of molecular and translational medicine, and full professor of medicine at Mainz University Medical Centre in Germany. He is also professor of medicine and senior visiting scientist at Harvard Medical School. Professor Pinzani is professor of medicine and gastroenterology at the University of Florence, Italy, and visiting professor in the division of hepatology at Osaka City School of Medicine in Japan.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC016695

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel